[ORGANIZATION]
Penn Medicine
Featured in 5 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
315 clusters · 1160 sources · last updated
Latest: GLP-1 weight loss drugs drive surge in protein-based products
The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. A large-scale U.S. study sug
Clinical applications and access of CAR-T and myeloma cell/m
21 clusters · 74 sources · last updated
Latest: CAR T-cell therapy shows promise for hairy cell leukemia
CAR-T cell therapy continues to expand its clinical utility across oncology and autoimmune diseases. In oncology, the therapy is transforming treatment for aggressive lymphomas and resistant blood cancers. A significant
Epic AI tool development and adoption
2 clusters · 6 sources · last updated
Latest: Epic develops autonomous AI agents for routine medical visits
Epic is advancing the development of autonomous artificial intelligence agents designed to manage routine patient encounters. These agents, intended for both inpatient and outpatient settings, are being engineered to gat
Impact of aging on sleep and cognition
3 clusters · 9 sources · last updated
Latest: Aging process linked to changes in human sleep patterns
Research and medical observations indicate that aging is associated with progressive changes in sleep architecture and cognitive function. Older adults often experience earlier bedtimes, earlier mornings, and more fragme
JAK inhibitor use in dermatological treatments
2 clusters · 4 sources · last updated
Latest: JAK inhibitors recommended over systemic steroids for skin conditions
Medical professionals are increasingly advocating for the use of Janus kinase (JAK) inhibitors as a primary treatment for skin conditions such as vitiligo, atopic dermatitis (AD), and alopecia areata. In the treatment